The single-cell analysis market is projected to reach USD 7.1 billion by 2028 from USD 3.5 billion in 2023, at a CAGR of 15.3% during the forecast period. The rapid development of advanced single-cell analysis technologies, rising prevalence of cancer, progress in stem cell research, substantial R&D investments and funding in pharmaceutical & biotechnology industries, increasing focus on personalized medicine. On the other hand, the high cost of single-cell analysis instruments is expected to hamper the market growth to a certain extent.
The prominent players operating in the single-cell analysis market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands) among others. The key players in this market are increasingly focusing on strategic partnerships and expansions, to expand their manufacturing capabilities and increase market presence.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific, Inc. (US)
Thermo Fisher Scientific was the largest player in the single-cell analysis market in 2022. The company is largely known for its diversified product offerings for the research industry. The company operates its business through four key segments—Laboratory Products & Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. With the acquisition of Life Technologies Corporation, the company established a new segment—Life Sciences Solutions—through which it offers single-cell analysis products. Thermo Fisher's single-cell analysis solutions are used in various applications, including genomics, transcriptomics, proteomics, and epigenomics.
Becton, Dickinson and Company (US)
Becton, Dickinson and Company (BD) is a global medical technology company engaged in developing, manufacturing, and sales of a wide range of devices, medical supplies, diagnostic products, and laboratory equipment. The company provides single-cell analysis products through the Biosciences segment. BD's single-cell analysis solutions are designed to support multi-omics research, enabling simultaneous analysis of multiple parameters within individual cells. This integrated approach facilitates a holistic understanding of cellular heterogeneity and molecular interactions, driving advancements in immunology, cancer biology, and stem cell research. To maintain its leading position and enhance its market share, the company mainly focuses on the launch and enhancement of products, thereby expanding its presence in the market.
Danaher Corporation (US)
Danaher was the third largest player in the single-cell analysis market. Danaher’s subsidiary companies including Beckman Coulter Life Sciences, Cytiva, Leica Biosystems, and Molecular Devices, offer a diverse range of instruments, reagents, software, and automation solutions dedicated to single-cell analysis applications. Danaher has undertaken several product launches, acquisitions, expansions, and collaborations to develop single-cell analysis products.
Merck KGaA (Germany)
Merck KGaA is among top players in the single-cell analysis market in 2022. Merck provides a diverse portfolio of tools and technologies specifically designed for single-cell analysis. These encompass a wide array of reagents, antibodies, and assays that facilitate the study of individual cells at the molecular level. Researchers can leverage these tools to analyze gene expression, protein profiling, and other key cellular characteristics in a single-cell context. Merck provides solutions for single-cell analysis, including products for genomics, transcriptomics, proteomics, and epigenomics. These solutions often include reagents, and kits that enable comprehensive analysis of single cells. The company focuses on product launches and deals with key players to leverage growth opportunities in the market.
Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE